Test Laboratories Clause Samples

The 'Test Laboratories' clause defines the requirements and standards for laboratories that conduct testing relevant to the agreement. It typically specifies that only laboratories accredited by recognized bodies or meeting certain quality standards may be used for testing products, materials, or processes. For example, it may require that all safety or compliance tests be performed by ISO-certified labs. This clause ensures that test results are reliable and credible, thereby reducing disputes over product quality or regulatory compliance.
Test Laboratories. The Test Laboratories agree to run three lab-financed Sequence VID tests on each Matrix test stand to ensure proper test calibration. The Matrix requires two stands at each Test Laboratory. These test stands will be considered calibrated upon the successful completion of the Sequence VID Test Matrix and in compliance with calibration criteria as determined by the Sequence VI Surveillance Panel. The calibration period will begin concurrently with the effective date of ACC registration of the VID. To maintain confidentiality of pricing information, the full and final prices paid to a Matrix Lab are shown only on that Matrix Lab’s copy of this MOA and the master copy kept by API.  Intertek Automotive Research will provide to ASTM, at no charge, the pertinent data and results of 6 tests for the Sequence VID matrix. Intertek also commits to conduct 16 tests for the Sequence VID matrix at the fixed full and final price of  Southwest Research Institute will provide to ASTM, at no charge, the pertinent data and results of 6 tests for the Sequence VID matrix. Southwest Research Institute also commits to conduct 16 tests for the Sequence VID matrix at the fixed full and final price of . All tests submitted by the Test Laboratories must be operationally valid. Operational validity of engine tests will be determined by the testing laboratory using guidance from the ASTM TMC and input from the Project Supervisor using guidelines established by the ASTM Sequence VI Surveillance Panel prior to the start of the matrix. Matrix tests that are determined to be operationally invalid will be re-run at the test laboratory’s expense. The Test Laboratories are not responsible for performing any testing beyond what is stated above. Sequence VID testing will begin when the test has been formally affirmed "ready for Matrix testing" by the PCEOCP and all other conditions set forth in Scope have been met. Testing shall be conducted in accordance with the approved Test Matrix (see Attachment). The targeted completion date for the Sequence VID Test Matrix is three (3) months after its commencement date. The stands included in the Test Matrix should be used exclusively for matrix testing until the assigned tests in those stands have been completed. The commencement date is the date that the first Matrix test begins. Extension of the timing past this targeted completion date must be approved by the ILSAC/Oil Committee.
Test Laboratories. Each Party shall notify the other of the test laboratories designated to carry out the tests pertaining to the procedures referred to in Article 10 of Directive 98/13/EC. The criteria fixed by the relevant harmonised standards for the designation of such laboratories shall be applied.
Test Laboratories. The Test Laboratories agree to provide the following resources to ASTM for use in the PC-10 Test Matrix. Caterpillar C13 Cummins ISB ▇▇▇▇ T-12 Lab Lab Financed Runs ACC/API/EMA Financed Runs Lab Financed Runs ACC/API/EMA Financed Runs Lab Financed Runs ACC/API/EMA Financed Runs SwRI To maintain confidentiality of pricing information, the full and final prices paid to a lab are shown only on that lab’s copy and the master copy kept by API. • PerkinElmer will provide to ASTM, at no charge, the pertinent data and results of ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) ▇▇▇▇ T-12 tests for the PC-10 matrix. PerkinElmer also commits to conduct ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) ▇▇▇▇ ▇-12 tests for the PC-10 matrix at the full and final price of • Southwest Research Institute will provide to ASTM, at no charge, the pertinent data and results of ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) ▇▇▇▇ T-12 tests for the PC-10 matrix. Southwest Research also commits to conduct ? (?) Caterpillar C13, ? (?) Cummins ISB, and ? (?) ▇▇▇▇ ▇-12 tests for the PC-10 matrix at the full and final price of . All tests submitted by the Test Laboratories must be operationally valid. Operational validity of engine tests will be determined by the testing laboratory using guidance from the ASTM Test Monitoring Center (hereinafter the "ASTM TMC") and input from the Project Manager using guidelines established by appropriate ASTM Surveillance Panels prior to the start of each matrix. Matrix tests that are determined to be operationally invalid will be re-run at the cost of the test laboratory. The Test Laboratories are not responsible for performing any testing beyond what is stated above. ASTM and the appropriate ASTM committees agree to act as the fund and test administrators for the PC-10 matrix. The responsibilities of ASTM and the ASTM committees are as follows: • ASTM will act as the fund-dispersing agency for the PC-10 matrix. API, ACC, and EMA will be invoiced as described above in Agreement Concerning Funding and Resources, section (a), second paragraph, according to the contribution level of each association. ASTM will disburse funds to the Test Laboratories on a per test basis. • ASTM HDEOCP will be responsible for the management of the PC-10 matrix testing. The PC-10 New Category Development Team (hereinafter the “PC-10 NCDT”) and API/EMA Diesel Engine Oil Advisory Panel (hereinafter the “DEOAP”) will provide oversight and guidance to the ASTM HDEO...

Related to Test Laboratories

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Laboratory Services Covered Services include prescribed diagnostic clinical and anatomic pathological laboratory services and materials when authorized by a Member's PCP and HPN’s Managed Care Program.

  • Specialty Prescription Drugs (+ Prorated copayments for a shorter supply period may apply for network pharmacy only. See Prescription Drug section for details. When purchased at a Specialty Pharmacy (+): For maintenance and non-maintenance prescription drugs, a copayment applies for each 30-day period (or portion thereof) within the prescribeddosing period. Tier 5: $125 Not Covered When purchased at a Retail Pharmacy (+): For maintenance and non-maintenance prescription drugs, a copayment applies for each 30-day period (or portion thereof) within the prescribeddosing period. Specialty Prescription Drugs purchasedat a retail pharmacy will require a significantly higher out of pocket expense than if purchased from a Specialty Pharmacy. Our reimbursement is based on the pharmacy allowance. Tier 5: 50% Not Covered When purchased at a Mail Order Pharmacy: Not Covered Not Covered Infertility Prescription Drugs - Three(3) in-vitro cycles will be covered per plan year with a total of eight (8) in-vitro cycles covered in a member’s lifetime. When purchased at a Specialty, Mail Order, or Retail Pharmacy Tier 1: 20% Not Covered Tier 2: 20% Not Covered Tier 3: 20% Not Covered Tier 4: 20% Not Covered When purchased at a Specialty Pharmacy (+) Tier 5: 20% Not Covered When purchased at a Retail Pharmacy (+): Specialty Prescription Drugs purchased at a retail pharmacy will require a significantly higher out of pocket expense than if purchased from a specialty pharmacy. Tier 5: 20% Not Covered Contraceptive Methods- Preventive Coverage includes barrier method (diaphragmor cervical cap), hormonal method (birth control pill), and emergency contraception. For non-preventive contraceptive prescription drugs and devices, the amount you pay will depend on the tier placement of the contraceptive prescription drug or device. See above for details. When purchased at a Retail Pharmacy: Up to a 365-day supply of contraceptive prescription drugs is available at all network retail pharmacies. For more information about this option, visit our website. Tier 1: $0 Not Covered When purchased at a Mail Order Pharmacy: Up to a 90-day supply. Tier 1: $0 Not Covered

  • Radiation Therapy/Chemotherapy Services This plan covers chemotherapy and radiation services. This plan covers respiratory therapy services. When respiratory services are provided in your home, as part of a home care program, durable medical equipment, supplies, and oxygen are covered as a durable medical equipment service.

  • Manufacturing Services Jabil will manufacture the Product in accordance with the Specifications and any applicable Build Schedules. Jabil will reply to each proposed Build Schedule that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within three (3) business days of receipt of any proposed Build Schedule. In the event of Jabil’s rejection of a proposed Build Schedule, Jabil’s notice of rejection will specify the basis for such rejection. When requested by Company, and subject to appropriate fee and cost adjustments, Jabil will provide Additional Services for existing or future Product manufactured by Jabil. Company shall be solely responsible for the sufficiency and adequacy of the Specifications [***].